BASF extends bid

BASF says it is extending, until 18 January 2013, the offer period for the company’s acquisition of all of the issued and outstanding shares of Pronova BioPharma (Lysaker, Norway)—a researcher, developer, and manufacturer of omega-3 fatty acids—for 12.50 Norwegian kroner/share, or NK4.84 billion ($853 million), in cash. The offer document was published on 5 December 2012. The offer is conditional on BASF receiving acceptances for more than 90% of the total share capital of Pronova. BASF said at CW press time that it had received acceptances from Pronova...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers